SLI - AEHL MOR and RNAZ among pre-market losers
2024-01-19 08:38:04 ET
More on pr-market losers & stocks.
- MorphoSys: Positive Pelabresib Data Finally Unlocking Upside
- MorphoSys: A Buying Opportunity Following Mixed Phase 3 Results In Myelofibrosis
- MorphoSys: Buying Constellation Was A Desperate Measure
- TransCode Therapeutics announces retirement of CEO
- MorphoSys climbs after late-stage data for blood cancer therapy
For further details see:
AEHL, MOR and RNAZ among pre-market losers